Education
About Us
Working with TipRanks
Follow Us
Regencell Bioscience (RGC)
NASDAQ:RGC
RGC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.08 - $83.60
Previous CloseN/A
Volume4.26K
Average Volume (3M)1.46M
Market Cap
$7.22B
Enterprise Value$11.35B
Total Cash (Recent Filing)$7.96M
Total Debt (Recent Filing)$85.74K
Price to Earnings (P/E)―
Beta-3.34
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Feb 15, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding494,488,920
10 Day Avg. Volume1,669,784
30 Day Avg. Volume1,464,767
Financial Highlights & Ratios
PEG Ratio-336.04
Price to Book (P/B)1.38K
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.57
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-450.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Regencell Bioscience News
Ownership Overview
―
Insiders
0.05%
Mutual Funds
― Other Institutional Investors
99.95% Public Companies and Individual Investors
RGC FAQ
What was Regencell Bioscience’s price range in the past 12 months?
Regencell Bioscience lowest stock price was $0.08 and its highest was $83.60 in the past 12 months.
What is Regencell Bioscience’s market cap?
Regencell Bioscience’s market cap is $7.22B.
When is Regencell Bioscience’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Regencell Bioscience’s earnings last quarter?
Currently, no data Available
Is Regencell Bioscience overvalued?
According to Wall Street analysts Regencell Bioscience’s price is currently Overvalued.
Does Regencell Bioscience pay dividends?
Regencell Bioscience pays a Quarterly dividend of $0.22 which represents an annual dividend yield of N/A. See more information on Regencell Bioscience dividends here
What is Regencell Bioscience’s EPS estimate?
Regencell Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regencell Bioscience have?
Regencell Bioscience has 494,488,920 shares outstanding.
What happened to Regencell Bioscience’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Regencell Bioscience?
Currently, no hedge funds are holding shares in RGC
Regencell Bioscience Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
RGC Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 67.6%
Last 30 Days ▲ 67.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17280.95%
12-Months-Change
Fundamentals
Return on Equity
-48.45%
Trailing 12-Months
Asset Growth
-28.60%
Trailing 12-Months
Company Description
Regencell Bioscience
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Technical Analysis
Pacific Biosciences
―
ClearPoint Neuro
―
Solid Biosciences
―
Allogene Therapeutics
―
Zenas BioPharma, Inc.
―